Revenue: The sum of all revenue fields included for a company's operating activities.
Travere Therapeutics, Inc. (TVTX) had Revenue of $233.18M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$233.18M |
$-321.55M |
|
$7.74M |
|
$225.43M |
|
$557.00M |
|
$-323.83M |
|
$3.32M |
|
$-320.51M |
|
$-320.51M |
|
$-320.63M |
|
$-320.63M |
|
$-321.55M |
|
$-320.63M |
|
$-323.83M |
|
$-283.08M |
|
78.89M |
|
78.89M |
|
$-4.08 |
|
$-4.08 |
|
| Balance Sheet Financials | |
$416.70M |
|
$5.34M |
|
$177.42M |
|
$594.12M |
|
$200.75M |
|
$310.31M |
|
$334.30M |
|
$535.05M |
|
$59.08M |
|
$-44.90M |
|
$59.08M |
|
87.45M |
|
| Cash Flow Statement Financials | |
$-237.47M |
|
$99.33M |
|
$139.42M |
|
$58.18M |
|
$58.53M |
|
$0.36M |
|
$36.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.08 |
|
-- |
|
-- |
|
0.84 |
|
6.42 |
|
96.68% |
|
-138.88% |
|
-138.88% |
|
-121.40% |
|
-137.45% |
|
-137.90% |
|
$-237.47M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
1.25 |
|
8.60 |
|
42.45 |
|
-542.73% |
|
714.15% |
|
-53.97% |
|
-86.80% |
|
$0.68 |
|
$-3.01 |
|
$-3.01 |
|